Orna Therapeutics Presents New Data Supporting its in vivo CAR Programs for Autoimmune Diseases and Oncology at the 67th American Society of Hematology Annual Meeting
Anti-CD19 panCARTM program (ORN-252) demonstrated robust B cell depletion with significant reduction in anti-dsDNA titers in humanized lupus model Anti-BCMA panCARTM... Read more.
Washable Area Rugs (2025): Rugs Direct Named Top Choice for Practical & Stylish Home Decor by Expert Consumers
NEW YORK, Dec. 7, 2025 /PRNewswire/ — Expert Consumers has named Rugs Direct the top choice for washable area rugs in 2025, recognizing the retailer’s... Read more.
Best Accounting Software for Self-Employed (2025): QuickBooks Named Top Choice for Freelancers and Entrepreneurs by Expert Consumers
NEW YORK, Dec. 7, 2025 /PRNewswire/ — Expert Consumers, an independent research group known for data-driven evaluations of software tools and digital services,... Read more.
Skymizerʼs HyperThought™ Wins “Best IP/Processor of the Yearˮ and “Most Promising Productˮ at EE Awards Asia 2025
TAIPEI, Dec. 6, 2025 /PRNewswire/ — Skymizer today announced that its next-generation HyperThought™ LLM Accelerator IP has been awarded “Best IP/Processor... Read more.
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China’s National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical... Read more.
SK hynix Honored with Two Major Titles at GSA Awards 2025
Company named “Best Financially Managed Semiconductor Company (Achieving Greater than $1 Billion in Annual Sales)” and “Outstanding Asia-Pacific... Read more.
MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition. BOSTON, Dec. 6, 2025... Read more.
Zenocutuzumab-zbco (BIZENGRI®) Shows Durable Efficacy in Patients with Treatment-Naïve NRG1+NSCLC: Updated eNRGy Trial Results Presented at IASLC-ASCO NACLC
LEXINGTON, Mass., Dec. 6, 2025 /PRNewswire/ — Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company, announced new data from... Read more.
Best HR and Payroll Software (2025): QuickBooks Awarded for Accuracy and Team Management by Better Business Advice
NEW YORK , Dec. 6, 2025 /PRNewswire/ — Better Business Advice has recognized QuickBooks as the Best HR and Payroll Software (2025) for its accuracy, team... Read more.
Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting
New long-term data presented at AES 2025 indicate reductions in seizure frequency are maintained for up to two years after treatment initiation with bexicaserin... Read more.